Veracyte Says Decipher Prostate Test Predicts Abiraterone Benefit
New evidence focuses on identifying patients with clinically very high-risk, nonmetastatic prostate cancer who may benefit from more intensive treatment. PRWire: SOUTH SAN FRANCISCO, California — Veracyte has announced research showing that its...












